10

Click here to load reader

D N A Of Biopreneur

Embed Size (px)

DESCRIPTION

What makes a successful entrepreneur in health care? Check this out. And join Biopreneur program at EDI,Ahmedabad

Citation preview

Page 1: D N A Of  Biopreneur

DNA of Biopreneur

A.S.Rao

Adviser-Innovation Clusters,FMC

[email protected]

http://www.indiainvents.blogspot.com/

Page 2: D N A Of  Biopreneur

Molecule millionaires

• Scientist turned promoter: Dr Anji Reddy (DPR), Ketan R Patel(Troikka), Krishna Ella (Bharat Biotech), Ramanbhai Patel(Cadia),

• Biopreneurs: Ranbir Singh & Gurbax Singh (Ranbaxy), UN Mehta (Torrent), VaraprasadReddy (Shanta Biotech), Raghavendra rao(Orchid)

Page 3: D N A Of  Biopreneur

Signature of success

• Master the virtuous cycle of knowledge management.

• Identify business opportunity, decipher key factors, relate to technology, acquire technology and raise the stock of Firm Specific Knowledge.

• Learn to network with knowledge partners and knowledge workers.

• Lead cluster formation as network orchestrator

Page 4: D N A Of  Biopreneur

Knowledge cycle

Business opportunity

Technology driver

Access knowledge

Acquire knowledge

Assimilate knowledge

Leverage knowledge

Take knowledge

dividend

Start next cycle

Page 5: D N A Of  Biopreneur

Opportunities

• Patents not enforced in India

• Drugs going off the patents

• Affordable health care

• 100 global technologies shortlisted by knowledge partner Sky Quest.

Page 6: D N A Of  Biopreneur

Patents not enforced in India

• http://www.globalinnovationcommons.org

• Buruli Ulcer, Dengue Fever, Dracunculiasis(Guinea Worm Disease), Leprosy, Lymphatic Filariasis, Malaria, Sickle Cell Anemia, Snake Bite, Spider Bite

Page 7: D N A Of  Biopreneur

Going off the patent

• 22 drugs will go off-patent in India by 2015-Rituxan, an anti-neoplastic mAbs from Roche; Lantus, an antidiabetics from Sanofi aventis; and Neulasta, an immunostimulants from Amgen; have record sales of $5.6 billion, $4.3 billion and $3.4 billion respectively. Similarly, Epogen from Amgen, Avonex from BiogenIdec, Eprex from Johnson & Johnson and Rebiffrom Merck, which reported sales of over $2 billion in 2009, will lose patents by 2013.

Page 8: D N A Of  Biopreneur

Affordable health care

• Service innovations: Eye care, Heart surgery, Tele medicine, remote monitoring of patients,

• Reverse innovations: from Innovators/ start-ups –Mosquito traps, infant warmers

• Non-profit design centers:

http://www.d-rev.org/index.html

Page 9: D N A Of  Biopreneur

Services needed

• Technology search, access, acquisition, negotiation

• Business plan

• Regulatory approvals

Page 10: D N A Of  Biopreneur

Biopreneur program

Opportunity Consultancy